Search Results - "Pasyar, S."

Hypofractionated, Dose-Escalated Radiation vs. Conventionally Fractionated Radiation for Localized Prostate Cancer: Long-Term Update of a Phase 3, Prospective, Randomized Controlled Trial by Hassanzadeh, C.J., Kuban, D.A., Pasyar, S., Bassett, R., Troncoso, P., Ansari, M.A., Schlembach, P.J., McGuire, S.E., Nguyen, Q.N., Frank, S.J., Mok, H., Mohamad, O., Park, R.J.H., Shah, S.J., Mayo, L.L., Tang, C., Du, W., Kudchadker, R., Choi, S., Hoffman, K.E.

“…The initial report of a prospective phase 3 randomized trial of dose-escalated, moderately hypofractionated versus conventionally fractionated radiation…”
Get full text

A Prospective Pilot Study Investigating 18F rhPSMA-7.3 PET/MRI to Detect Recurrent Disease and Guide Radiotherapy Planning in Patients with Biochemically Recurrent Prostate Cancer Post-Prostatectomy by Surasi, D.S., Bathala, T., Choi, S., Shah, S.J., Nguyen, Q.N., Hoffman, K.E., Mayo, L.L., Mok, H., Frank, S.J., Fang, A., Sheth, R., Hwang, K.P., Mawlawi, O.R., Macapinlac, H., Troncoso, P., Zhang, M., Pasyar, S., Bassett, R., Chapin, B., Tang, C.

“…Simultaneous PET/MRI imaging has the advantage of combining metabolic information from PET with the high-spatial resolution of MRI to identify disease with…”
Get full text